These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 7457310

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia.
    Pohl R, Berchou R, Rainey JM.
    J Clin Psychopharmacol; 1982 Dec; 2(6):399-407. PubMed ID: 7174863
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Is buspirone effective for panic disorder?
    Sheehan DV, Raj AB, Sheehan KH, Soto S.
    J Clin Psychopharmacol; 1990 Feb; 10(1):3-11. PubMed ID: 2407755
    [Abstract] [Full Text] [Related]

  • 5. Imipramine in the treatment of agoraphobia: dose-response relationships.
    Mavissakalian M, Perel J.
    Am J Psychiatry; 1985 Sep; 142(9):1032-6. PubMed ID: 3895987
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of phenelzine on the prolapsed mitral valve in a patient with agoraphobia with panic attacks.
    Evans DL, Kalina K.
    J Clin Psychopharmacol; 1983 Feb; 3(1):36-8. PubMed ID: 6833522
    [No Abstract] [Full Text] [Related]

  • 8. Phenelzine and exposure in the treatment of phobias.
    Solyom C, Solyom L, LaPierre Y, Pecknold J, Morton L.
    Biol Psychiatry; 1981 Mar; 16(3):239-47. PubMed ID: 6112024
    [Abstract] [Full Text] [Related]

  • 9. The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia.
    Mavissakalian M, Perel JM, Michelson L.
    J Clin Psychopharmacol; 1984 Feb; 4(1):36-40. PubMed ID: 6693582
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antidepressant medication in the treatment of agoraphobia: a critical review.
    Telch MJ, Tearnan BH, Taylor CB.
    Behav Res Ther; 1983 Feb; 21(5):505-17. PubMed ID: 6140001
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Psychopharmacologic validation of atypical depression.
    Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin JG, Tricamo E, Markowitz JS, Klein DF.
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483
    [Abstract] [Full Text] [Related]

  • 17. Antidepressants in the treatment of agoraphobia and obsessive-compulsive disorder.
    Mavissakalian M.
    Compr Psychiatry; 1983 Jul; 24(3):278-84. PubMed ID: 6347516
    [No Abstract] [Full Text] [Related]

  • 18. [Phenelzin in agoraphobia].
    Lerner J.
    Harefuah; 1974 Nov 15; 87(10):463. PubMed ID: 4435606
    [No Abstract] [Full Text] [Related]

  • 19. A naturalistic study of imipramine in panic disorder and agoraphobia.
    Aronson TA.
    Am J Psychiatry; 1987 Aug 15; 144(8):1014-9. PubMed ID: 3300374
    [Abstract] [Full Text] [Related]

  • 20. Agoraphobia: the 'what if' syndrome.
    Fier M.
    J Med Soc N J; 1981 Apr 15; 78(4):286-8. PubMed ID: 6939897
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.